How Can Erchonia-DPN Help?
The Erchonia-DPN Laser is an FDA-cleared low-level laser therapy device indicated for treatment of pain associated with diabetic peripheral neuropathy.
FDA Clearance K251903
The Erchonia-DPN Laser has received FDA clearance (K251903) as a prescription device for the treatment of symptoms associated with diabetic peripheral neuropathy. This clearance is based on rigorous clinical evaluation demonstrating safety and effectiveness.
Clinical Study Outcomes
*Percentage improvement reported from FDA-cleared clinical study.
How Erchonia-DPN Works
The Erchonia-DPN Laser uses proprietary red and violet laser energy to support nerve health and cellular function.
Laser Energy Absorbed by Photoreceptors
Red and violet laser energy is absorbed by photoreceptors within the tissue.
Stimulates Mitochondrial Function
Laser energy supports mitochondrial activity and ATP production.
Supports Nerve Function
Enhanced cellular energy supports normal nerve function.
Relieves Pain
Patients experience meaningful relief from neuropathic pain.
Laser Energy Absorbed by Photoreceptors
Red and violet laser energy is absorbed by photoreceptors within the tissue.
Stimulates Mitochondrial Function
Laser energy supports mitochondrial activity and ATP production.
Supports Nerve Function
Enhanced cellular energy supports normal nerve function.
Relieves Pain
Patients experience meaningful relief from neuropathic pain.
Relief. Restoration. Renewed Life.